跳至主要内容
临床试验/NCT05678413
NCT05678413招募中不适用

Role of Paclitaxel in Prevention of Stricture Recurrence After Direct Visual Internal Urethrotomy (DVIU); Prospective Clinical Trial

Al-Azhar University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2022年6月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1
主要终点
Success of treatment

研究概览

简要总结

Stricture urethra is a common disease and has various causing factors. The most common performed procedure is direct visual internal urethrotomy (DVIU), but unfortunately has a high recurrence rates. Multiple trial were performed to improve the outcomes of DVIU. Various intralesional injections were used. in this trial we will evaluate intralesional paclitaxel injection following DVIU.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
否

入选标准

  • •Anterior urethral stricture
  • •Short strictures (less than 2 cm)
  • •International Prostate Symptom Score less than 11 and maximum flow rate < 15 ml per second.
  • •No previous treatment for stricture disease

排除标准

  • •Recurrent cases
  • •Prior pelvic radiation
  • •Associated other pathology or unresolved confounding etiologies (e.g. bladder neck contracture, neurogenic bladder, benign prostatic hyperplasia) were excluded.

研究组 & 干预措施

DVIU with paclitaxel

Active Comparator

Cystourethroscopy will be performed using a 22 Fr rigid cystoscope to allow for ureteric catheter 3F/a wire to be passed through the stricture and into the urinary bladder. DVIU will be performed by cold-knife incisions at the 12-, 3-, and 9 o'clock positions through the full thickness of the fibrosis to healthier appearing tissue. A 23 Fr Wolf (Vernon Hills, IL) injection scope and a standard injection needle was used to inject 30 mg/5mL of paclitaxel vial, 1.5 mL will be injected along the length of each incision into healthier appearing tissue for a total of 5 mL.

干预措施: DVIU with paclitaxel injection (Procedure)

DVIU

Active Comparator

Cystourethroscopy will be performed using a 22 Fr rigid cystoscope to allow for ureteric catheter 3F/a wire to be passed through the stricture and into the urinary bladder. DVIU will be performed by cold-knife incisions at the 12-, 3-, and 9 o'clock positions through the full thickness of the fibrosis to healthier appearing tissue.

干预措施: DVIU (Procedure)

结局指标

主要结局

Success of treatment

时间窗: 1 year

Treatment free rates (Freedom from repeat intervention e.g., repeat dilation, DVIU or urethroplasty).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Fawzy Abd Elfattah Salman

Director

Al-Azhar University

研究点 (1)

Loading locations...

相似试验